GLP-1 receptors exist in the parietal cortex, hypothalamus and medulla of human brains and the GLP-1 analogue liraglutide alters brain activity related to highly desirable food cues in individuals with diabetes: a crossover, randomised, placebo-controlled trial
Olivia M. Farr(Harvard University), Christos S. Mantzoros(Beth Israel Deaconess Medical Center), Fadime Dincer(Beth Israel Deaconess Medical Center), Nickole Kanyuch(Beth Israel Deaconess Medical Center), Chrysoula Liakou(St Savas Hospital), Michael Sofopoulos(St Savas Hospital), Byung‐Joon Ko(Unknown), Michael A. Tsoukas(McGill University Health Centre), Anna Gavrieli(Beth Israel Deaconess Medical Center), Ayse Sahin-Efe(Beth Israel Deaconess Medical Center), Alexandra Srnka(Beth Israel Deaconess Medical Center), Andreas Filippaios(Beth Israel Deaconess Medical Center), Sofia Tseleni‐Balafouta(National and Kapodistrian University of Athens), Bindiya Thakkar(Beth Israel Deaconess Medical Center), Jennifer M. Bowers(Beth Israel Deaconess Medical Center)
Cited by 273
Related Papers
Role of leptin in the neuroendocrine response to fasting
|Nature|1996|3.1k
Adverse metabolic and cardiovascular consequences of circadian misalignment
|Proceedings of the National Academy of Sciences|2009|2.3k
Obesity and cancer risk: Emerging biological mechanisms and perspectives
|Metabolism|2018|1.6k
Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics
|Metabolism|2018|1.2k